Publication de 6 numéros par an
ISSN Imprimer: 0743-4863
ISSN En ligne: 2162-660X
Indexed in
RNA-Interference Effectors and Their Delivery
RÉSUMÉ
RNA-interference, the mechanism by which the expression of a specific protein can be reduced or eliminated, has emerged as a potential way to treat disease. RNA-interference effectors, such as small interfering RNA and small hairpin RNA, are double-stranded nucleic acid sequences expressly designed to have homology to sections of the target protein's mRNA, and when present in the cytosol trigger hydrolysis of the mRNA through the RNA-interference pathway. Because RNA-interference effectors are macromolecular and typically polyanionic, their efficacy is poor when not accompanied by a delivery vehicle. This review outlines the RNA-interference mechanism and discusses the delivery of RNA-interference effectors, with an emphasis on synthetic polymer-based delivery systems.
-
Transfection Technologies, in Handbook of Biochemistry and Molecular Biology, Fourth Edition, 2010. Crossref
-
Salem Aliasger K., Behlke Mark A., SiRNA Delivery Vehicles, in RNA Interference, 2010. Crossref
-
Ghonaim Hassan M., Li Shi, Blagbrough Ian S., Very Long Chain N 4 ,N 9 -Diacyl Spermines: Non-Viral Lipopolyamine Vectors for Efficient Plasmid DNA and siRNA Delivery, Pharmaceutical Research, 26, 1, 2009. Crossref
-
Richardt-Pargmann Denise, Vollmer Jörg, Stimulation of the Immune System by Therapeutic Antisense Oligodeoxynucleotides and Small Interfering RNAs via Nucleic Acid Receptors, Annals of the New York Academy of Sciences, 1175, 1, 2009. Crossref
-
Ghonaim Hassan M., Li Shi, Blagbrough Ian S., N 1,N 12 -Diacyl Spermines: SAR Studies on Non-viral Lipopolyamine Vectors for Plasmid DNA and siRNA Formulation, Pharmaceutical Research, 27, 1, 2010. Crossref
-
De Laporte Laura, Shea Lonnie D., Matrices and scaffolds for DNA delivery in tissue engineering, Advanced Drug Delivery Reviews, 59, 4-5, 2007. Crossref
-
de Martimprey H., Vauthier C., Malvy C., Couvreur P., Polymer nanocarriers for the delivery of small fragments of nucleic acids: Oligonucleotides and siRNA, European Journal of Pharmaceutics and Biopharmaceutics, 71, 3, 2009. Crossref
-
Alshamsan Aws, Hamdy Samar, Samuel John, El-Kadi Ayman O.S., Lavasanifar Afsaneh, Uludağ Hasan, The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine, Biomaterials, 31, 6, 2010. Crossref
-
Branco Monica C., Schneider Joel P., Self-assembling materials for therapeutic delivery, Acta Biomaterialia, 5, 3, 2009. Crossref
-
Fischer J., Kolk A., Wolfart St., Pautke C., Warnke P.H., Plank C., Smeets R., Future of local bone regeneration – Protein versus gene therapy, Journal of Cranio-Maxillofacial Surgery, 39, 1, 2011. Crossref
-
Zheng Xiaowen, Li Qian, Ma Lie, Gao Changyou, Skin Regeneration, in Polymeric Biomaterials for Tissue Regeneration, 2016. Crossref
-
Clima L., Rotara A., Cojocaru C., Pinteala M., Simionescu B. C., Polymer engineering focusing on DRUG/GENE delivery and tissue engineering, 2015 E-Health and Bioengineering Conference (EHB), 2015. Crossref
-
Oku Naoto, Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases, Biological & Pharmaceutical Bulletin, 40, 2, 2017. Crossref
-
Ashrafizadeh Milad, Ahmadi Zahra, Kotla Niranjan G., Afshar Elham Ghasemipour, Samarghandian Saeed, Mandegary Ali, Pardakhty Abbas, Mohammadinejad Reza, Sethi Gautam, Nanoparticles Targeting STATs in Cancer Therapy, Cells, 8, 10, 2019. Crossref
-
Blagbrough Ian S., Metwally Abdelkader A., Ghonaim Hassan M., Asymmetrical N4,N9-Diacyl Spermines: SAR Studies of Nonviral Lipopolyamine Vectors for Efficient siRNA Delivery with Silencing of EGFP Reporter Gene, Molecular Pharmaceutics, 9, 7, 2012. Crossref
-
Alshamsan Aws, Haddadi Azita, Incani Vanessa, Samuel John, Lavasanifar Afsaneh, Uludağ Hasan, Formulation and Delivery of siRNA by Oleic Acid and Stearic Acid Modified Polyethylenimine, Molecular Pharmaceutics, 6, 1, 2009. Crossref
-
Saad Maha, Garbuzenko Olga B, Minko Tamara, Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer, Nanomedicine, 3, 6, 2008. Crossref